The primary aim of this study was to investigate the association between NPS and CSF biomarkers for synaptic and axonal degeneration, i.e., levels of CSF Ng, GAP-43, and NFL in AD and other cognitive disorders. Here, NRGN is linked to Alzheimer disease.